News Highlights

Check this page for recent news from Appili Therapeutics.

Members of the media can contact us here, or for general inquiries, contact us here.

September 14, 2020
Appili Therapeutics to Commence Trading on Main Board of the TSX Exchange
September 11, 2020
Appili Submits Protocol for a Phase 3 Study Evaluating Favipiravir for the Treatment of Patients with COVID-19 Infections to the US FDA
September 10, 2020
Appili Therapeutics to Participate in Upcoming Investor Conferences for H.C. Wainwright & Co. and Maxim Group LLC
August 14, 2020
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2021
August 13, 2020
Appili Therapeutics Announces Voting Results of Annual and Special Meeting of Shareholders